SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-031615
Filing Date
2023-11-13
Accepted
2023-11-13 16:10:19
Documents
15
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atxi20230822_8k.htm   iXBRL 8-K 24774
2 EXHIBIT 99.1 ex_563742.htm EX-99.1 97244
7 ex_563742img001.jpg GRAPHIC 10600
  Complete submission text file 0001437749-23-031615.txt   278435

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20230930.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20230930_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20230930_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20230930_pre.xml EX-101.PRE 11585
9 EXTRACTED XBRL INSTANCE DOCUMENT atxi20230822_8k_htm.xml XML 2573
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 231398769
SIC: 2834 Pharmaceutical Preparations